DreaMed Diabetes Israeli Company
Founded in 2014, DreaMed pioneered the first artificial pancreas technology. Since then, DreaMed has dedicated itself to developing decision-support tools in the diabetes management field. We are the world’s first and only company to receive FDA clearance for a decision support system that utilizes data from CGM/SMBG (continuous glucose monitoring/self-monitoring of blood glucose) and insulin pumps.
Health Tech & Life Sciences
Artificial Intelligence (AI)
Biotechnology
Diabetes
Enterprise Software
Health Care
Medical Device
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
Suggest an Alternative
Parent Companies/Investors
Office Locations
Kefar Sava, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/dreamed-diabetes
[2]
crunchbase.com
- https://www.crunchbase.com/organization/dreamed-diabetes
External links are provided for reference and verification purposes.